Drug Profile
Research programme: Escherichia coli vaccine - GangaGen
Latest Information Update: 20 Oct 2021
Price :
$50
*
At a glance
- Originator GangaGen
- Class Bacterial vaccines; Escherichia coli vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Escherichia coli infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Escherichia-coli-infections in USA
- 15 Jul 2016 Early research in Escherichia coli infections in USA (unspecified route)